Abstract
Few areas of pharmaceuticals have seen the fast-moving developments in the
marketplace that the vaccine market has in 2007 and 2008. Since Kalorama
Information last updated Kalorama Information' s The World Market for Vaccines
in the first quarter of last year, new products and better than expected
profits have transformed the vaccine marketplace. Approvals that have been
granted for products such as RotaTeq, Pentacel, Adacel and Zostavax and
FluMist are now impacting the market. The launch and execution of the first
successful cancer vaccine product, Merck' s Gardasil, has had dramatic and
surprising results. Other products also exceeded revenue expectations. The
competitive dynamics have changed with merger activity, and many new products
are on the way.
Kalorama vaccine market analyst Allison Sahoo' s exhaustive research and
analysis of interviews with key decision makers in the market includes the
following:
- Review of Products in the Market
- Current World Market Size for Pediatric and Adult Vaccines
- Segmented Revenues and Forecasts to 2013 by Category
- Over 45 Charts and Tables To Make Information Accessible
- Important Vaccines and Immunization Schedules and Statistics
- Discussion of Issues and Trends in the Vaccine Market
- Profiles of 15 Key Vaccine Companies
- Thorough Review of the Vaccine Pipeline and Possible Impact of New Products
Who are the main players in the vaccine market? What opportunities are
available for pharmaceutical companies or investors from this market? What are
the potential challenges vaccine competitors must deal with? What will be the
impact of the first successful cancer product? What is the significance of at
least one major acquisition to affect this industry? These questions and more
are tackled in this report.
Current revenues and revenue forecasts to 2013 are included for the following
pediatric vaccine categories:
- DTaP & DTP Vaccines
- Hep Vaccines
- HiB Vaccines
- MMR Vaccines
- Combination Vaccines
- Pneumococcal Vaccines
- Polio Vaccines
- Varicella Vaccines
- Other Pediatric Vaccines
As well as Revenues and Forecasts to 2012 for the following adult vaccine
categories:
- Influenza Vaccines
- Hepatitis Vaccines
- Pneumococcal Vaccines
- Travel, DT and other Adult Vaccines
- Cervical Cancer
This is a rapidly changing marketplace and knowledge of the R&D pipeline is
essential to truly understand what is happening in vaccines. Vaccines in
development are discussed in this report, including vaccines for the following
conditions:
- Enterotoxigenic Escherichia coli
- Parainfluenza Virus Type 3
- Pneumococcal Vaccines
- Respiratory Syncytial Virus
- Cancers
- Cholera
- HIV/AIDS
- Helicobacter Pylori
- Malaria
- Rabies
- Tuberculosis
- West Nile Virus
This Kalorama Information report was created with a primary research effort -
interviews with market experts in the vaccine market who shared insights,
informed of new trends and helped to construct models, supplemented by
secondary research in company, medical and trade literature. Marketing and
Business Development executives, strategic planners, research and development
executives, as well as investors and financial consultants are among those who
will find this a useful resource.
View Cart
